USD 146.66
(2.12%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - USD | -100.0% |
2022 | 151 Million USD | -3.21% |
2021 | 156 Million USD | -1.89% |
2020 | 159 Million USD | 15.22% |
2019 | 138 Million USD | -8.61% |
2018 | 151 Million USD | 3.42% |
2017 | 146 Million USD | 18.7% |
2016 | 123 Million USD | -20.17% |
2015 | 154.08 Million USD | -7.19% |
2014 | 166.02 Million USD | 20.63% |
2013 | 137.62 Million USD | 30.81% |
2012 | 105.21 Million USD | 29.84% |
2011 | 81.03 Million USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q3 | 195 Million USD | 0.0% |
2024 Q2 | - USD | 0.0% |
2024 Q1 | - USD | 0.0% |
2023 Q2 | 179 Million USD | 8.48% |
2023 Q3 | 177 Million USD | -1.12% |
2023 Q4 | - USD | -100.0% |
2023 FY | - USD | -100.0% |
2023 Q1 | 165 Million USD | 9.27% |
2022 Q1 | 162 Million USD | 3.85% |
2022 FY | 151 Million USD | -3.21% |
2022 Q2 | 188 Million USD | 16.05% |
2022 Q4 | 151 Million USD | -14.2% |
2022 Q3 | 176 Million USD | -6.38% |
2021 Q3 | 164 Million USD | -7.87% |
2021 Q2 | 178 Million USD | 11.95% |
2021 Q1 | 159 Million USD | 0.0% |
2021 FY | 156 Million USD | -1.89% |
2021 Q4 | 156 Million USD | -4.88% |
2020 Q4 | 159 Million USD | -3.64% |
2020 FY | 159 Million USD | 15.22% |
2020 Q1 | 173 Million USD | 25.36% |
2020 Q2 | 146 Million USD | -15.61% |
2020 Q3 | 165 Million USD | 13.01% |
2019 Q2 | 180 Million USD | 17.65% |
2019 Q3 | 150 Million USD | -16.67% |
2019 Q1 | 153 Million USD | 1.32% |
2019 FY | 138 Million USD | -8.61% |
2019 Q4 | 138 Million USD | -8.0% |
2018 Q2 | 158 Million USD | 6.76% |
2018 FY | 151 Million USD | 3.42% |
2018 Q4 | 151 Million USD | -1.95% |
2018 Q3 | 154 Million USD | -2.53% |
2018 Q1 | 148 Million USD | 1.37% |
2017 Q1 | 134 Million USD | 8.94% |
2017 FY | 146 Million USD | 18.7% |
2017 Q4 | 146 Million USD | 0.0% |
2017 Q3 | 146 Million USD | -4.58% |
2017 Q2 | 153 Million USD | 14.18% |
2016 FY | 123 Million USD | -20.17% |
2016 Q4 | 123 Million USD | 105.46% |
2016 Q3 | 59.86 Million USD | -14.4% |
2016 Q2 | 69.93 Million USD | 17.71% |
2016 Q1 | 59.41 Million USD | -61.44% |
2015 Q3 | 165.92 Million USD | -6.02% |
2015 Q2 | 176.56 Million USD | -2.19% |
2015 Q1 | 180.5 Million USD | 8.72% |
2015 FY | 154.08 Million USD | -7.19% |
2015 Q4 | 154.08 Million USD | -7.14% |
2014 Q2 | 152.97 Million USD | 2.58% |
2014 Q3 | 149.22 Million USD | -2.45% |
2014 Q1 | 149.12 Million USD | 8.35% |
2014 FY | 166.02 Million USD | 20.63% |
2014 Q4 | 166.02 Million USD | 11.26% |
2013 Q3 | 114.98 Million USD | -1.16% |
2013 FY | 137.62 Million USD | 30.81% |
2013 Q2 | 116.33 Million USD | 3.52% |
2013 Q1 | 112.37 Million USD | 6.81% |
2013 Q4 | 137.62 Million USD | 19.69% |
2012 FY | 105.21 Million USD | 29.84% |
2012 Q4 | 105.21 Million USD | 0.0% |
2011 FY | 81.03 Million USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Agilent Technologies, Inc. | 1.03 Billion USD | 100.0% |
Charles River Laboratories International, Inc. | 380.25 Million USD | 100.0% |
Quest Diagnostics Incorporated | 190 Million USD | 100.0% |
Danaher Corporation | 2.59 Billion USD | 100.0% |
Enzo Biochem, Inc. | 6.83 Million USD | 100.0% |
Laboratory Corporation of America Holdings | 474.6 Million USD | 100.0% |
Mettler-Toledo International Inc. | 385.86 Million USD | 100.0% |
Qiagen N.V. | 398.38 Million USD | 100.0% |
Revvity, Inc. | 428.06 Million USD | 100.0% |
Thermo Fisher Scientific Inc. | 5.08 Billion USD | 100.0% |
Waters Corporation | 516.23 Million USD | 100.0% |